Can a full-body MRI catch cancer early in people at high risk?

Original Title

Evaluation of whole-body MRI for cancer early detection in Li-Fraumeni syndrome

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

This study looked at whether yearly full-body MRIs help find cancer early in people with a strong genetic risk for many cancers.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

The sensitivity of 42.9% is shockingly low for a high-stakes surveillance tool in a population with 80% lifetime cancer risk.

Most assume annual imaging in high-risk groups is highly effective — but this study shows it misses nearly half of cancers, contradicting the assumption that 'more scans = better protection.'

Practical Takeaways

If you or a loved one has Li-Fraumeni syndrome, understand that a 'normal' MRI means no cancer *today* — not that you’re safe until next year. Stay vigilant for new symptoms.

medium confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.

41%
Moderate QualityOverall Score

Publication

Journal

Journal of Medical Genetics

Year

2025

Authors

Peter Sodde, Z. Hyder, Sarah Pugh, F. Lalloo, R. Martin, C. Soh, Jawad Naqvi, R. Whitehouse, D. G. Evans, E. Woodward

Open Access
Analysis v1
Can a full-body MRI catch cancer early in people at high risk? — Quality Score & Summary | Fit Body Science